A novel test enables real-time monitoring of T cells that have been engineered to fight cancer, after re-introduction into the body of a cancer patient. This simple and innovative test provides ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Growing investments in healthcare, rising research and development activities, and the development of optimized 3D assays are propelling the market forward. Biotechnology and pharmaceutical industries ...